GOV.UK
Existing emergency measures banning the sale and supply of puberty-suppressing hormones will be made indefinite, following official advice from medical experts.
The Commission on Human Medicines (CHM) has provided independent expert advice that there is currently an unacceptable safety risk in the continued prescription of puberty blockers to children. It recommends indefinite restrictions while work is done to ensure the safety of children and young people.
The NHS stopped the routine prescription of puberty blocker treatments to under 18s in March 2024, following the Cass Review into gender identity services.
